Cite
Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials.
MLA
Kaigang Xie, et al. “Platinum-Based Adjuvant Therapy Was Efficient for Triple-Negative Breast Cancer: A Meta-Analysis from Randomized Controlled Trials.” Bioengineered, vol. 13, no. 6, June 2022, pp. 14827–39. EBSCOhost, https://doi.org/10.1080/21655979.2022.2115616.
APA
Kaigang Xie, Xuanlei Ren, Xiaoming Hong, Shuiyin Zhu, Dongjie Wang, Xiaoming Ye, & Xiaoting Ren. (2022). Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials. Bioengineered, 13(6), 14827–14839. https://doi.org/10.1080/21655979.2022.2115616
Chicago
Kaigang Xie, Xuanlei Ren, Xiaoming Hong, Shuiyin Zhu, Dongjie Wang, Xiaoming Ye, and Xiaoting Ren. 2022. “Platinum-Based Adjuvant Therapy Was Efficient for Triple-Negative Breast Cancer: A Meta-Analysis from Randomized Controlled Trials.” Bioengineered 13 (6): 14827–39. doi:10.1080/21655979.2022.2115616.